cetilistat
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Cetilistat is a pancreatic lipase inhibitor approved for management of obesity, following the serious adverse effects exhibited…
To describe the treatment of obesity from ancient times to present day.
Lipoprotein lipase (LPL) is the rate-limiting enzyme for the hydrolysis of the triglyceride (TG) core of circulating TG-rich…
Obesity is a modern plague in industrialized and developing countries, and currently overweight and obesity cause more deaths…
The Present invention relates two Compositions Comprising Cetilistat, inciuding its saits, esters, amides, solvates, polymorphs…
Obesity prevalence has risen dramatically over the past decades, which poses a great number of patients at risk of metabolic and…
Pharmacotherapy of obesity should be an integral part of the comprehensive obesity management program which includes diet…
AIMS
To assess the efficacy, pharmacodynamics, safety and tolerability of a range of doses of cetilistat, a novel inhibitor of…
Cetilistat is a novel inhibitor of pancreatic lipase. The aim of this report is to evaluate the anti-obesity action of cetilistat…